Stress-dependent hypertension and the role of T lymphocytes

Experimental Physiology

Volumn 97, Issue 11, 2012, Pages 1161-1167

  Marvar, Paul J ^a   Harrison, David G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868199379     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.061507     Document Type: Review

References (64)

1. Aguilera G, Kiss A, Luo X & Akbasak BS (1995). The renin angiotensin system and the stress response. Ann N Y Acad Sci 771, 173-186.
2. Anderson EA, Sinkey CA, Lawton WJ & Mark AL (1989). Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14, 177-183.
3. Black PH (2006). The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 67, 879-891.
4. Brody M, Fink G, Buggy J, Haywood J, Gordon F, Knuepfer M, Mow M, Mahoney L & Johnson A (1978). Critical role of the AV3V region in development and maintenance of experimental hypertension. In Perspectives in Nephrology and Hypertension, ed. Schmitt H & Meyers P, pp. 76-84. Wiley and Flammarion, New York, NY
5. Brody MJ (1988). Central nervous system and mechanisms of hypertension. Clin Physiol Biochem 6, 230-239.
6. Brody MJ & Johnson AK (1980). Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation, and hypertension Frontiers in Neuroendocrinology. Raven Press, New York, NY Frontiers in Neuroendocrinology, edited by Martini L and Ganong WF. New York: Raven Press, 1980, p. 249-292.
7. Carrasco GA & Van de Kar LD (2003). Neuroendocrine pharmacology of stress. Eur J Pharmacol 463, 235-272.
8. Chapleau MW, Li Z, Meyrelles SS, Ma X & Abboud FM (2001). Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann N Y Acad Sci 940, 1-19.
9. Clamage DM, Sanford CS, Vander AJ & Mouw DR (1976). Effects of psychosocial stimuli on plasma renin activity in rats. Am J Physiol 231, 1290-1294.
10. Crowley SD, Song YS, Lin EE, Griffiths R, Kim HS & Ruiz P (2010). Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 298, R1089-R1097.
11. Cuttica MJ, Langenickel T, Noguchi A, Machado RF, Gladwin MT & Boehm M (2011). Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage. Am J Respir Cell Mol Biol 45, 62-71.
12. Davern PJ, Chen D, Head GA, Chavez CA, Walther T & Mayorov DN (2009). Role of angiotensin II Type 1A receptors in cardiovascular reactivity and neuronal activation after aversive stress in mice. Hypertension 54, 1262-1268.
13. Davern PJ & Head GA (2007). Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 49, 1170-1177.
14. Davern PJ & Head GA (2011). Role of the medial amygdala in mediating responses to aversive stimuli leading to hypertension. Clin Exp Pharmacol Physiol 38, 136-143.
15. De Miguel C, Guo C, Lund H, Feng D & Mattson DL (2011). Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol 300, F734-F742.
16. Dendorfer A, Thornagel A, Raasch W, Grisk O, Tempel K & Dominiak P (2002). Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension 40, 348-354.
17. DiBona GF & Jones SY (2001). Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla. Hypertension 37, 1114-1123.
18. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Dawood T, Kaye D, Barton D, Pier C, Guo L, Brenchley C, Jennings G & Lambert E (2008). Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol 35, 498-502.
19. Evans RG, Head GA, Eppel GA, Burke SL & Rajapakse NW (2010). Angiotensin II and neurohumoral control of the renal medullary circulation. Clin Exp Pharmacol Physiol 37, e58-e69.
20. Ferrario CM & Strawn WB (2006). Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98, 121-128.
21. Ganta CK, Lu N, Helwig BG, Blecha F, Ganta RR, Zheng L, Ross CR, Musch TI, Fels RJ & Kenney MJ (2005). Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Am J Physiol Heart Circ Physiol 289, H1683-H1691.
22. Gard PR (2002). The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 438, 1-14.
23. Gasperin D, Netuveli G, Dias-da-Costa JS & Pattussi MP (2009). Effect of psychological stress on blood pressure increase: a meta-analysis of cohort studies. Cad Saude Publica 25, 715-726.
24. Glaser R & Kiecolt-Glaser JK (2005). Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5, 243-251.
25. Grassi G, Seravalle G & Quarti-Trevano F (2010). The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95, 581-586.
26. Groeschel M & Braam B (2011). Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system. Am J Physiol Renal Physiol 300, F1-F10.
27. Guyenet PG (2006). The sympathetic control of blood pressure. Nat Rev Neurosci 7, 335-346.
28. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C & Harrison DG (2007). Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204, 2449-2460.
29. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A & Weyand CM (2011). Inflammation, immunity, and hypertension. Hypertension 57, 132-140.
30. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C & Harrison DG (2009). Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 296, R208-R216.
31. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G & Friberg P (1999). Increased sympathetic nerve activity in renovascular hypertension. Circulation 99, 2537-2542.
32. Krause EG, de Kloet AD, Scott KA, Flak JN, Jones K, Smeltzer MD, Ulrich-Lai YM, Woods SC, Wilson SP, Reagan LP, Herman JP & Sakai RR (2011). Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress. J Neurosci 31, 15009-15015.
33. Liu F, Havens J, Yu Q, Wang G, Davisson RL, Pickel VM & Iadecola C (2012). The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress. Int J Physiol Pathophysiol Pharmacol 4, 28-35.
34. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ & Harrison DG (2010). Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 55, 277-283, 6p following 283.
35. McDougall SJ, Lawrence AJ & Widdop RE (2005). Differential cardiovascular responses to stressors in hypertensive and normotensive rats. Exp Physiol 90, 141-150.
36. McKinley MJ, McAllen RM, Davern P, Giles ME, Penschow J, Sunn N, Uschakov A & Oldfield BJ (2003). The sensory circumventricular organs of the mammalian brain. Adv Anat Embryol Cell Biol 172, III-XII, 1-122, back cover.
37. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ & Harrison DG (2010). Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55, 500-507.
38. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ & Harrison DG (2010). Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107, 263-270.
39. Marvar PJ, Vinh A, Thabet S, Lob HE, Geem D, Ressler KJ & Harrison DG (2012). T Lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biol Psychiatry 71, 774-782.
40. Matsukawa T, Gotoh E, Hasegawa O, Shionoiri H, Tochikubo O & Ishii M (1991). Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension. J Hypertens 9, 537-542.
41. Matthews KA, Katholi CR, McCreath H, Whooley MA, Williams DR, Zhu S & Markovitz JH (2004). Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation 110, 74-78.
42. Moretti JL, Burke SL, Davern PJ, Evans RG, Lambert GW & Head GA (2012). Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits. J Hypertens 30, 551-560.
43. Muller DN, Kvakan H & Luft FC (2011). Immune-related effects in hypertension and target-organ damage. Curr Opin Nephrol Hypertens 20, 113-117.
44. Nance DM & Sanders VM (2007). Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21, 736-745.
45. Nyklicek I, Bosch JA & Amerongen AV (2005). A generalized physiological hyperreactivity to acute stressors in hypertensives. Biol Psychol 70, 44-51.
46. Osborn JW, Fink GD, Sved AF, Toney GM & Raizada MK (2007). Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9, 228-235.
47. Paton JF & Waki H (2009). Is neurogenic hypertension related to vascular inflammation of the brainstem Neurosci Biobehav Rev 33, 89-94.
48. Pickering TG (2007). Stress, inflammation, and hypertension. J Clin Hypertens (Greenwich) 9, 567-571.
49. Raasch W, Wittmershaus C, Dendorfer A, Voges I, Pahlke F, Dodt C, Dominiak P & Jöhren O (2006). Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology 147, 3539-3546.
50. Rodriguez-Iturbe B (2010). Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension. Clin Exp Nephrol 14, 105-111.
51. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA & Esler MD (2000). Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 36, 824-829.
52. 1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36, 1-18.
53. Saiki Y, Watanabe T, Tan N, Matsuzaki M & Nakamura S (1997). Role of central ANG II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am J Physiol 272, R26-R33.
54. Sanders VM & Straub RH (2002). Norepinephrine, the β-adrenergic receptor, and immunity. Brain Behav Immun 16, 290-332.
55. Shi P, Raizada MK & Sumners C (2010). Brain cytokines as neuromodulators in cardiovascular control. Clin Exp Pharmacol Physiol 37, e52-e57.
56. Sunn N, McKinley MJ & Oldfield BJ (2003). Circulating angiotensin II activates neurones in circumventricular organs of the lamina terminalis that project to the bed nucleus of the stria terminalis. J Neuroendocrinol 15, 725-731.
57. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V & Egido J (2003). Inflammation and angiotensin II. Int J Biochem Cell Biol 35, 881-900.
58. von Bohlen und Halbach O & Albrecht D (1998). Mapping of angiotensin AT1 receptors in the rat limbic system. Regul Pept 78, 51-56.
59. Waki H, Gouraud SS, Maeda M & Paton JF (2010). Evidence of specific inflammatory condition in nucleus tractus solitarii of spontaneously hypertensive rats. Exp Physiol 95, 595-600.
60. Waki H, Gouraud SS, Maeda M, Raizada MK & Paton JF (2011). Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol 178, 422-428.
61. + T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57, 949-955.
62. Weiner N (1979). Multiple factors regulating the release of norepinephrine consequent to nerve stimulation. Fed Proc 38, 2193-2202.
63. Yu Y, Zhang ZH, Wei SG, Serrats J, Weiss RM & Felder RB (2010). Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction. Hypertension 55, 652-659.
64. Zhang M, Mao Y, Ramirez SH, Tuma RF & Chabrashvili T (2010). Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171, 852-858.